Bavituximab's Mechanism of Action Highlighted at Immunomodulatory ... Marketwire (press release) TUSTIN, CA--(Marketwired - Aug 14, 2013) - Peregrine Pharmaceuticals, Inc. ( NASDAQ : PPHM) today announced the presentation of preclinical data and ongoing drug development activities highlighting the immune-stimulatory mechanism of action of ... |
